Nicardipine Equity 10 mg Solution for Injection
PDF Leaflet Revision Date: 18 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Acute life-threatening hypertension.
Dosage (summary)
Initial: 3-5 mg/h; max: 15 mg/h; maintenance: 2-4 mg/h.
Onset of Action / Duration
Onset: 5-15 mins, Duration: varies.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Use in pregnancy not established; contraindicated in breastfeeding.
Key Drug Interactions
- Beta-blockers
- Dantrolene
- Magnesium
- CYP3A inducers/inhibitors
Contraindications
- Hypersensitivity
- Mitral/aortic stenosis
- Unstable angina
- Recent myocardial infarction
Common side effects
- Headache
- Dizziness
- Peripheral oedema
- Palpitations
- Flushing
Counselling Points
- Monitor blood pressure continuously
- Infusion only via electronic pump
- Avoid breastfeeding during treatment
Serious warnings
- Severe hypotension
- Caution in cardiac failure
- Risk of maternal hypotension in pregnancy
Important Disclaimer
The Nicardipine Equity 10 mg Solution for Injection professional information leaflet below is the property of Equity Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
